Loss of heterozygosity in oral cancer

Oral Science International

Volumn 8, Issue 2, 2011, Pages 37-43

  Kasamatsu, Atsushi ^a,b   Uzawa, Katsuhiro ^a,b   Usukura, Katsuya ^a   Koike, Kazuyuki ^a   Nakashima, Dai ^a   Ishigami, Takashi ^a   Fushimi, Kazuaki ^a   Ogawara, Katsunori ^b   Shiiba, Masashi ^b   Tanzawa, Hideki ^a,b  

^a CHIBA UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Loss of heterozygosity; Oral squamous cell carcinoma; Tumor suppressor gene

Indexed keywords

EID: 84857846279     PISSN: 13488643     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1348-8643(11)00027-9     Document Type: Review

References (86)

1. Nakanishi H., Uzawa K., Yokoe H., et al. Rare mutations of the growth suppressor genes involved in negative regulation of the cell cycle. Int J Oncol 1997, 11:1129-1133.
2. Yamamoto N., Uzawa K., Miya T., et al. Frequent allelic loss/imbalance on the long arm of chromosome 21 in oral cancer: evidence for three discrete tumor suppressor gene loci. Oncol Rep 1999, 6:1223-1227.
3. Yamamoto N., Mizoe J.E., Numasawa H., et al. Allelic loss of chromosome 2 in human oral squamous cell carcinoma: correlation with lymph node metastasis. Oral Oncol 2003, 39:64-68.
4. Wang X.L., Uzawa K., Imai F.L., et al. Localization of a novel tumor suppressor gene associated with human oral cancer on chromosome 4q25. Oncogene 1999, 18:823-825.
5. Wang X., Uzawa K., Nakanishi H., et al. Allelic imbalance on the long arm of chromosome 5 in oral squamous cell carcinoma. Int J Oncol 1997, 10:535-538.
6. Wang X.L., Uzawa K., Miyakawa A., et al. Localization of tumor-suppressor gene associated with human oral cancer on 7q31.1. Int J Cancer 1998, 75:671-674.
7. Ono K., Miyakawa A., Fukuda M., et al. Allelic loss on the short arm of chromosome 8 in oral squamous cell carcinoma. Oncol Rep 1999, 6:785-789.
8. Nakanishi H., Wang X.L., Imai F.L., et al. Localization of a novel tumor suppressor gene loci on chromosome 9p21-22 in oral cancer. Anticancer Res 1999, 19:29-34.
9. Yamashita Y., Miyakawa A., Mochida Y., et al. Genetic aberration on chromosome 10 in human oral squamous cell carcinoma. Int J Oncol 2002, 20:595-598.
10. Uzawa K., Suzuki H., Komiya A., et al. Evidence for two distinct tumor-suppressor gene loci on the long arm of chromosome 11 in human oral cancer. Int J Cancer 1996, 67:510-514.
11. Uzawa K., Yoshida H., Suzuki H., et al. Abnormalities of the adenomatous polyposis coli gene in human oral squamous-cell carcinoma. Int J Cancer 1994, 58:814-817.
12. Ogawara K., Miyakawa A., Shiba M., et al. Allelic loss of chromosome 13q14.3 in human oral cancer: correlation with lymph node metastasis. Int J Cancer 1998, 79:312-317.
13. Watanabe T., Wang X., Miyakawa A., et al. Mutational state of tumor suppressor genes (DCC, DPC4) and alteration on chromosome 18q21 in human oral cancer. Int J Oncol 1997, 11:1287-1290.
14. Imai F.L., Uzawa K., Miyakawa A., et al. A detailed deletion map of chromosome 20 in human oral squamous cell carcinoma. Int J Mol Med 2001, 7:43-47.
15. Araki D., Uzawa K., Watanabe T., et al. Frequent allelic losses on the short arm of chromosome 1 and decreased expression of the p73 gene at 1p36.3 in squamous cell carcinoma of the oral cavity. Int J Oncol 2002, 20:355-360.
16. Yamamoto N., Uzawa K., Yakushiji T., et al. Analysis of the ANA gene as a candidate for the chromosome 21q oral cancer susceptibility locus. Br J Cancer 2001, 84:754-759.
17. Miyakawa A., Wang X.L., Nakanishi H., et al. Allelic loss on chromosome 22 in oral cancer: possibility of the existence of a tumor suppressor gene on 22q13. Int J Oncol 1998, 13:705-709.
18. Severino1 P., Alvares A.M., Michaluart P., et al. Global gene expression profiling of oral cavity cancers suggests molecular heterogeneity within anatomic subsites. BMC Res Notes 2008, 1:113.
19. Scully C., Field J.K., Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control. Oral Oncol 2000, 36:256-263.
20. Scully C., Field J.K., Tanzawa H. Genetic aberrations in oral or head and neck squamous cell carcinoma 3: clinico-pathological applications. Oral Oncol 2000, 36:404-413.
21. Sticht C., Freier K., Knöpfle K., et al. Activation of MAP kinase signaling through ERK5 but not ERK1 expression is associated with lymph node metastases in oral squamous cell carcinoma (OSCC). Neoplasia 2008, 10:462-470.
22. Fearon E.R. Tumor suppressor genes. The genetic basis of human cancer 2002, 197-206. McGraw-Hill, New York. 2nd ed. B. Vogelstein, K.W. Kinzler (Eds.).
23. Chiba I., Shindoh M., Yasuda M., et al. Mutations in the p53 gene and human papillomavirus infection as significant prognostic factors in squamous cell carcinomas of the oral cavity. Oncogene 1996, 18:1663-1668.
24. Largery J.S., Meltzer S.J., Sauk J.J., et al. Loss of heterozygosity involving the APC gene in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol 1994, 77:260-263.
25. Heinzel P.A., Balaram P., Bernard H.U. Mutations and polymorphisms in the p53, p21 and p16 genes in oral carcinomas of Indian betel quid chewers. Int J Cancer 1996, 68:420-423.
26. Miracca E.C., Kowalski L.P., Nagai M.A. High prevalence of p16 genetic alterations in head and neck tumours. Br J Cancer 1999, 81:677-683.
27. Weinberg R.A. Tumor suppressor genes. Science 1991, 254:1138-1146.
28. Marshall C.J. Tumor suppressor genes. Cell 1991, 64:313-326.
29. Ohta M., Inoue H., Cotticelli M.G., et al. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 1996, 84:587-597.
30. Sudbo J., Reith A. The evolution of predictive oncology and molecularbased therapy for oral cancer prevention. Int J Cancer 2005, 115:339-345.
31. Sudbo J. Novel management of oral cancer: a paradigm of predictive oncology. Clin Med Res 2004, 2:233-242.
32. Das B.R., Nagpal J.K. Understanding the biology of oral cancer. Med Sci Monit 2002, 8:258-267.
33. Okamoto M., Nishimine M., Kishi M., et al. Prediction of delayed neck metastasis in patients with stage I/II squamous cell carcinoma of the tongue. J Oral Pathol Med 2002, 31:227-233.
34. Massano J., Regateiro F.S., Januario G., et al. Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006, 102:67-76.
35. Ensley JF, Gutkind JS, Jacobs J.R., et al. Head and neck cancer: emerging perspectives 2003, Academic Press, New York, pp. 151-166.
36. Greenlee R.T., Murray T., Bolden S., et al. Cancer statistics, 2000. CA Cancer J Clin 2000, 50:7-33.
37. Epstein J.B., Zhang L., Rosin M. Advances in the diagnosis of oral premalignant and malignant lesions. J Can Dent Assoc 2002, 68:617-621.
38. Mehrotra R., Yadav S. Oral squamous cell carcinoma: etiology, pathogenesis and prognostic value of genomic alterations. Indian J Cancer 2006, 43:60-66.
39. Mashberg A., Boffetta P., Winkelman R., et al. Tobacco smoking, alcohol drinking, and cancer of the oral cavity and oropharynx among U.S. veterans. Cancer 1993, 72:1369-1375.
40. Macfarlane G.J., Zheng T., Marshall J.R., et al. Alcohol, tobacco, diet and the risk of oral cancer: a pooled analysis of three case-control studies. Eur J Cancer B Oral Oncol 1995, 31B:181-187.
41. Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990, 61:759-767.
42. Mithani S.K., Mydlarz W.K., Grumbine F.L., et al. Molecular genetics of premalignant oral lesions. Oral Dis 2007, 13:126-133.
43. Califano J., van der Riet P., Westra W., et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996, 56:2488-2492.
44. Velasco A., Pallares J., Santacana M., et al. Loss of heterozygosity in endometrial carcinoma. Int J Gynecol Pathol 2008, 27:305-317.
45. Ross D.W. Introduction to oncogenes and molecular cancer medicine 1998, Springer-Verlag, New York, p. 45.
46. Kapitanovic S., Cacev T., Radosevic S., et al. APC gene loss of heterozygosity, mutations, E1317Q, and I1307K germ-line variants in sporadic colon cancer in Croatia. Exp Mol Pathol 2004, 77:193-200.
47. Knudson A.G. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971, 68:820-823.
48. Tang B., Bottinger E.P., Jakowlew S.B., et al. Transforming growth factor-h1 is a new form of tumor suppressor with true haploid insufficiency. Nat Med 1998, 4:802-807.
49. Bai F., Pei X.H., Godfrey V.L., et al. Haploinsufficiency of p18 (INK4c) sensitizes mice to carcinogen-induced tumorigenesis. Mol Cell Biol 2003, 23:1269-1277.
50. Cacev T., Radosevic S., Spaventi R., et al. NF1 gene loss of heterozygosity and expression analysis in sporadic colon cancer. Gut 2005, 54:1129-1135.
51. Zheng H.T., Peng Z.H., Zhou C.Z., et al. Detailed deletion mapping of loss of heterozygosity on 22q13 in sporadic colorectal cancer. World J Gastroenterol 2005, 11:1668-1672.
52. Zhou C.Z., Qiu G.Q., Fan J.W., et al. Refined mapping of loss of heterozygosity on 1q31.1-32.1 in sporadic colorectal carcinoma. World J Gastroenterol 2008, 14:1582-1587.
53. Wan J., Li H., Li Y., et al. Loss of heterozygosity of Kras 2 gene on 12p12-13 in Chinese colon carcinoma patients. World J Gastroenterol 2009, 12:1033-1037.
54. Zhou C.Z., Qiu G.Q., Zhang F., et al. Loss of heterozygosity on chromosome 1 in sporadic colorectal carcinoma. World J Gastroenterol 2004, 10:1431-1435.
55. Howell R.E., Wong F.S., Fenwick R.G. Loss of Harvey ras heterozygosity in oral squamous carcinoma. J Oral Pathol Med 1989, 18:79-83.
56. Ah-See K.W., Cooke T.G., Pickford I.R., et al. An allelotype of squamous carcinoma of the head and neck using microsatellite markers. Cancer Res 1994, 54:1617-1621.
57. Latif F., Fivash M., Glenn G., et al. Chromosome 3p deletions in head and neck carcinomas: statistical ascertainment of allelic loss. Cancer Res 1992, 52:1451-1456.
58. Partridge M., Kiguwa S., Langdon J.D. Frequent deletion of chromosome 3p in oral squamous cell carcinoma. Eur J Cancer B Oral Oncol 1994, 30B:248-251.
59. Maestro R., Gasparotto D., Vukosavljevic T., et al. Three discrete regions of deletion at 3p in head and neck cancers. Cancer Res 1993, 53:5775-5779.
60. Virgilio L., Shuster M., Gollin S.M., et al. FHIT gene alterations in head and neck squamous cell carcinomas. Proc Natl Acad Sci USA 1996, 93:9770-9775.
61. González M.V., Pello M.F., Ablanedo P., et al. Chromosome 3p loss of heterozygosity and mutation analysis of the FHIT and beta-cat genes in squamous cell carcinoma of the head and neck. J Clin Pathol 1998, 51:520-524.
62. Uzawa N., Yoshida M.A., Hosoe S., et al. Functional evidence for involvement of multiple putative tumor suppressor genes on the short arm of chromosome 3 in human oral squamous cell carcinogenesis. Cancer Genet Cytogenet 1998, 107:125-131.
63. Hamana K., Uzawa K., Ogawara K., et al. Monitoring of circulating tumour-associated DNA as a prognostic tool for oral squamous cell carcinoma. Br J Cancer 2005, 92:2181-2184.
64. Kuroiwa T., Yamamoto N., Onda T., et al. Expression of the FAM5C in tongue squamous cell carcinoma. Oncol Rep 2009, 22:1005-1011.
65. Jamieson T.A., Brizel D.M., Killian J.K., et al. M6P/IGF2R loss of heterozygosity in head and neck cancer associated with poor patient prognosis. BMC Cancer 2003, 3:4.
66. Coon S.W., Savera A.T., Zarbo R.J., et al. Prognostic implications of loss of heterozygosity at 8p21 and 9p21 in head and neck squamous cell carcinoma. Int J Cancer 2004, 111:206-212.
67. Poetsch M., Zimmermann A., Wolf E., et al. Loss of heterozygosity occurs predominantly, but not exclusively, in the epithelial compartment of pleomorphic adenoma. Neoplasia 2005, 7:688-695.
68. Ohta S., Uemura H., Matsui Y., et al. Alterations of p16 and p14ARF genes and their 9p21 locus in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009, 107:81-91.
69. Beder L.B., Gunduz M., Ouchida M., et al. Genome-wide analyses on loss of heterozygosity in head and neck squamous cell carcinomas. Lab Invest 2003, 83:99-105.
70. Fleischer M., Kessler R., Klammer A., et al. LOH on 10p14-p15 targets the PFKFB3 gene locus in human glioblastomas. Genes Chromosomes Cancer 2011, 50:1010-1020.
71. Katase N., Gunduz M., Beder L.B., et al. Frequent allelic loss of Dkk-1 locus (10q11.2) is related with low distant metastasis and better prognosis in head and neck squamous cell carcinomas. Cancer Invest 2010, 28:103-110.
72. Gasparotto D., Vukosavljevic T., Piccinin S., et al. Loss of heterozygosity at 10q in tumors of the upper respiratory tract is associated with poor prognosis. Int J Cancer 1999, 84:432-436.
73. Sheng Z.M., Barrois M., Klijanienko J., et al. Analysis of the c-Ha-ras-1 gene for deletion, mutation, amplification and expression in lymph node metastases of human head and neck carcinomas. Br J Cancer 1990, 62:398-404.
74. Nawroz H., van der Riet P., Hruban R.H., et al. Allelotype of head and neck squamous cell carcinoma. Cancer Res 1994, 54:1152-1155.
75. Steenbergen R.D., Hermsen M.A., Walboomers J.M., et al. Integrated human papillomavirus type 16 and loss of heterozygosity at 11q22 and 18q21 in an oral carcinoma and its derivative cell line. Cancer Res 1995, 55:5465-5471.
76. Sabbir M.G., Roy A., Mandal S., et al. Deletion mapping of chromosome 13q in head and neck squamous cell carcinoma in Indian patients: correlation with prognosis of the tumour. Int J Exp Pathol 2006, 87:151-161.
77. Maestro R., Piccinin S., Doglioni C., et al. Chromosome 13q deletion mapping in head and neck squamous cell carcinomas: identification of two distinct regions of preferential loss. Cancer Res 1996, 56:1146-1150.
78. Chien H.T., Liao C.T., Huang S.F., et al. Clinical significance of genome-wide minimally deleted regions in oral squamous cell carcinomas. Genes Chromosomes Cancer 2011, 50:358-369.
79. Choi H.R., Batsakis J.G., Callender D.L., et al. Molecular analysis of chromosome 16q regions in dermal analogue tumors of salivary glands: a genetic link to dermal cylindroma. Am J Surg Pathol 2002, 26:778-783.
80. Fromont G., Vallancien G., Validire P., et al. BCAR1 expression in prostate cancer: association with 16q23 LOH status, tumor progression and EGFR/KAI1 staining. Prostate 2007, 67:268-273.
81. Nicoll G., Crichton D.N., McDowell H.E., et al. Expression of the hypermethylated in cancer gene (HIC-1) is associated with good outcome in human breast cancer. Br J Cancer 2001, 85:1878-1882.
82. Yu J., Liu P., Cui X., et al. Identification of novel subregions of LOH in gastric cancer and analysis of the HIC1 and TOB1 tumor suppressor genes in these subregions. Mol Cells 2011, 32:47-55.
83. Reis P.P., Rogatto S.R., Kowalski L.P., et al. Quantitative real-time PCR identifies a critical region of deletion on 22q13 related to prognosis in oral cancer. Oncogene 2002, 21:6480-6487.
84. Lea I.A., Jackson M.A., Li X., et al. Genetic pathways and mutation profiles of human cancers: site- and exposure-specific patterns. Carcinogenesis 2007, 28:1851-1858.
85. Lazo P.A. The molecular genetics of cervical carcinoma. Br J Cancer 1999, 80:2008-2018.
86. Egashira A., Morita M., Yoshida R., et al. Loss of p53 in esophageal squamous cell carcinoma and the correlation with survival: analyses of gene mutations, protein expression, and loss of heterozygosity in Japanese patients. J Surg Oncol 2011, 104:169-175.